EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metformin Resistance Is Associated with Expression of Inflammatory and Invasive Genes in A549 Lung Cancer Cells

Dong Soo Seo, Sungmin Joo, Seungwoo Baek, Jaehyeon Kang, Taeg Kyu Kwon iD, Younghoon Jang iD

Genes · 2023

DOI: 10.3390/genes14051014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2023. Verfasst von Dong Soo Seo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology and Chemistry, Changwon National University, Changwon 51140, Republic of Korea. Hauptthemen laut MEDLINE: Metformin, Diabetes Mellitus, Type 2, Lung Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF), Changwon National University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metformin, the most commonly used drug for type 2 diabetes, has recently been shown to have beneficial effects in patients with cancer. Despite growing evidence that metformin can inhibit tumor cell proliferation, invasion, and metastasis, studies on drug resistance and its side effects are lacking. Here, we aimed to establish metformin-resistant A549 human lung cancer cells (A549-R) to determine the side effects of metformin resistance. Toward this, we established A549-R by way of prolonged treatment with metformin and examined the changes in gene expression, cell migration, cell cycle, and mitochondrial fragmentation. Metformin resistance is associated with increased G1-phase cell cycle arrest and impaired mitochondrial fragmentation in A549 cells. We demonstrated that metformin resistance highly increased the expression of proinflammatory and invasive genes, including BMP5, CXCL3, VCAM1, and POSTN, using RNA-seq analysis. A549-R exhibited increased cell migration and focal adhesion formation, suggesting that metformin resistance may potentially lead to metastasis during anti-cancer therapy with metformin. Taken together, our findings indicate that metformin resistance may lead to invasion in lung cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminDiabetes Mellitus, Type 2Lung NeoplasmsHumansA549 CellsCell Proliferation

Stichwörter der Autor:innen

A549 lung cancer cellsdrug resistanceinvasive genesmetforminproinflammatory genes

Substanzen

Metformin

Autor:innen und Institutionen

  • Department of Biology and Chemistry, Changwon National University, Changwon 51140, Republic of Korea.
  • Department of Immunology, School of Medicine, Keimyung University, Daegu 42601, Republic of Korea.

ORCID-Profile: Taeg Kyu Kwon, Younghoon Jang

Förderung

  • National Research Foundation of Korea (NRF)
  • Changwon National University

Zitieren

APA

Seo, D. S., Joo, S., Baek, S., Kang, J., Kwon, T. K., & Jang, Y. (2023). Metformin Resistance Is Associated with Expression of Inflammatory and Invasive Genes in A549 Lung Cancer Cells. Genes. https://doi.org/10.3390/genes14051014

Vancouver

Seo DS, Joo S, Baek S, Kang J, Kwon TK, Jang Y. Metformin Resistance Is Associated with Expression of Inflammatory and Invasive Genes in A549 Lung Cancer Cells. Genes. 2023. doi:10.3390/genes14051014

BibTeX
@article{Seo2023,
  author = {Seo, Dong Soo and Joo, Sungmin and Baek, Seungwoo and Kang, Jaehyeon and Kwon, Taeg Kyu and Jang, Younghoon},
  title = {Metformin Resistance Is Associated with Expression of Inflammatory and Invasive Genes in A549 Lung Cancer Cells},
  journal = {Genes},
  year = {2023},
  doi = {10.3390/genes14051014}
}
Kostenlos starten →